AdozelesinAlternative Names: Adosar; U 73975
Latest Information Update: 02 May 2008
At a glance
- Originator Pharmacia Corporation
- Developer Pharmacia Corporation; Yakult Honsha
- Class Antineoplastics; Cyclohexanes; Indoles
- Mechanism of Action Alkylating agents; DNA inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Breast cancer; Cancer; Solid tumours